From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

ProPharma

Aurevia

Spatial Biology Studies in Lung Tissue using Spectral Microscopy

Spectral imaging with the ZEISS LSM 980 laser scanning confocal enables more complex studies of cell-cell interactions and locations in immunology research.

Exakt tryckreglering med Tescom – när precision är avgörande

OEM Automatic erbjuder ett brett sortiment av tryckregulatorer från Tescom – anpassade för att möta höga krav inom allt från gasleveranssystem till avancerad in...

AI detects tumor disease – via voice recording

A short voice recording along with facial images – both analyzed with an AI algorithm – can make it possible to detect the rare tumour disease acromegaly and in...

Don't miss ZEISS Quality Innovation Days

Digital event April 15-19, 2024.

Oncozenges tablett mot munsmärta utlicensieras för Gulf-regionen

Oncozenge har ingått ett licensavtal med Dubaibaserade Avernus Pharma om kommersialisering i Gulf-regionen av Bupizenge, en sugtablett under utveckling för beha...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

Wusson Accelerator AB

En slang med många möjligheter

Med hygieniska slangar från Xtraflex har vi slangar som passar väl för applikationer inom dryck-, livsmedel-, läkemedel-, och kosmetikaindustrin.

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

Japanese pharma to buy US drugmaker for $2.4 bln

Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.

Osäkerhet kring IVF-reform i USA – svenskt bolag backar

Vita huset backar från Donald Trumps vallöfte om att öka tillgången till fertilitetsbehandlingar. Svenskt medicinteknikbolaget faller ytterligare efter beskedet.

Positiva data för vaccin i pulverform – ”Fungerar lika bra”

En ny studie indikerar att ett nytt influensavaccin, som utvecklas av Abera Bioscience i samarbete med Orexo, fungerar både som sprej och pulver.

Faster development of reliable sample handling

to integrate into the customer's platform – with standard components from Festo, a PerkinElmer® JANUS G3 workstation and a modified rotary gripper module. This ...

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

The Swedish Foundation for Strategic Research

Study: Chat GPT is more empathetic than doctors

The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic t...

Smartcella tar in 50 miljoner euro – och stärker banden med Astra Zeneca

Bioteknikbolaget Smartcella har tagit in 50 miljoner euro, motsvarande omkring 580 miljoner kronor, i en nyemission. För hälften av kapitalet står läkemedelsjät...

“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

Enhance your expertise with your measuring software

Discover the training options in our ZEISS Metrology Portal.

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.